Audit 39180

FY End
2022-06-30
Total Expended
$36.15M
Findings
0
Programs
33
Year: 2022 Accepted: 2023-01-24

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.855 Allergy, Immunology and Transplantation Research $3.42M Yes 0
93.351 Research Infrastructure Programs $490,180 Yes 0
93.310 Trans-Nih Research Support $480,164 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $364,795 Yes 0
93.396 Cancer Biology Research $349,407 Yes 0
12.420 Military Medical Research and Development $331,790 Yes 0
93.398 Cancer Research Manpower $168,507 Yes 0
93.395 Cancer Treatment Research $146,605 Yes 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $128,854 Yes 0
93.RD Intraoperative Sampline of Fallopian Tubes $114,411 Yes 0
93.837 Cardiovascular Diseases Research $113,646 Yes 0
93.866 Aging Research $100,602 Yes 0
93.859 Biomedical Research and Research Training $98,751 Yes 0
93.103 Food and Drug Administration_research $87,326 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $76,052 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $46,475 Yes 0
93.RD A Randomized, Placebo-Controlled Trial of Tol-463 $32,499 Yes 0
93.350 National Center for Advancing Translational Sciences $31,980 Yes 0
93.433 Acl National Institute on Disability, Independent Living, and Rehabilitation Research $29,448 Yes 0
93.113 Environmental Health $26,519 Yes 0
93.279 Drug Abuse and Addiction Research Programs $26,138 Yes 0
93.394 Cancer Detection and Diagnosis Research $25,105 Yes 0
98.RD Usaid Foreign Assistance for Programs Overseas $23,448 Yes 0
93.361 Nursing Research $22,937 Yes 0
93.393 Cancer Cause and Prevention Research $20,648 Yes 0
98.001 Usaid Foreign Assistance for Programs Overseas $16,199 Yes 0
93.RD Ccn0138/c - Daily Oral Low Dose Ulipristal Acetate $12,993 Yes 0
93.865 Child Health and Human Development Extramural Research $11,485 Yes 0
93.233 National Center on Sleep Disorders Research $10,062 Yes 0
93.RD Contraceptive Development Program Nichd Female Sites $7,225 Yes 0
47.041 Engineering $1,915 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $1,510 Yes 0
93.RD Release Assays From Eva Rings $-13,599 Yes 0

Contacts

Name Title Type
J3Z5MNJJ3FZ4 Lisa Ascencio Auditee
4126418957 Elizabeth E. Krisher Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: MWRIF has elected to not use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (Schedule) includes the federal award activity of Magee-Womens Research Institute and Foundation (MWRIF) under programs of the federal government for the year ended June 30, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of MWRIF, it is not intended to and does not present the financial position, changes in net assets, or cash flows of MWRIF.